Stock Exchange disclosures
- Resignation of Chief Risk Officer of the Company
- Appointment of Chief Risk Officer and Reconstitution of Risk Management Committee
- Re-constitution of Risk Management Committee - 12.11.2024
- Exercise of ESOP - 08.11.2024
- Adjudication Order passed by SEBI - 04/11/2024
- Transcript of Earnings Conference Call dated October 18, 2024
- Corporate Governance Report for quarter ended September 30, 2024
- Audio recording of Earnings Conference Call dated October 18, 2024
- Reconciliation of Share Capital for the Quarter ended September 30, 2024
- Report on Related Party Transactions for the quarter and half-year ended September 2024
- Outcome of Board Meeting held on October 17, 2024
- Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2024
- Investor Grievance Report for the Quarter ended September 2024
- Intimation of Board Meeting dated October 17, 2024
- Intimation of trading window closure for the quarter and half year ended September 2024
- Exercise of ESOP - 25.09.2024
- Exercise of ESOP - 08.08.2024
- Announcement under Regulation 30 of LODR - 02.08.2024
- Transcript of Earnings Conference Call dated July 16, 2024
- Corporate Governance Report for quarter ended June 30, 2024
- Reconciliation of Share Capital for the Quarter ended June 30, 2024
- Audio recording of Earnings Conference Call dated July 16, 2024
- Exercise of ESOP - 12.07.2024
- Announcement under Regulation 30 of LODR-12.07.2024
- Outcome of Board Meeting held on July 12, 2024
- Disclosure under Regulation 30 of SEBI LODR-06.07.2024
- Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2024
- Investor Grievance Report for the Quarter ended June 2024
- Intimation of Board Meeting dated July 12, 2024
- Disclosure under Regulation 30 of SEBI LODR-02.07.2024
- Intimation of trading window closure for the quarter ended June 2024
- Exercise of ESOP - 20.06.2024
- Exercise of ESOP - 04.06.2024
- Disclosure under Reg 30 of SEBI LODR - Resignation of Mr. Narayan Gangadhar, MD & CEO
- Exercise of ESOP - 21.05.2024
- Exercise of ESOP - 24.04.2024
- Outcome of Board Meeting held on April 24, 2024
- Intimation of Board Meeting dated April 24, 2024